CompletedNCT01034072

Iron Overload in Pediatric Oncology Patients

Studying Rare hereditary hemochromatosis

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Northwell Health
Principal Investigator
Jonathan Fish, MD
Feinstein Institute for Medical Research
Enrollment
75 target
Eligibility
25 years · All sexes
Timeline
20092012

Study locations (1)

Collaborators

Novartis

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT01034072 on ClinicalTrials.gov

Other trials for Rare hereditary hemochromatosis

Additional recruiting or active studies for the same condition.

See all trials for Rare hereditary hemochromatosis

← Back to all trials